Emkay Global Financial's research report on ICICI Bank
ICICI Bank posted a 3% beat on PAT at Rs117bn and a superior RoA of 2.4% among peers, primarily due to healthy NII and better fees/treasury gains. Defying industry and peer trends, the bank clocked healthy credit growth at 15% YoY/4% QoQ, driven by some pick-up in corporate, business banking, and non-PL retail book. Deposit growth was equally healthy at 16% YoY/5% QoQ, while the bank maintains reasonable LCR at 120%. Amid most peers reporting higher NPAs, ICICIB continues to witness steady improvement in GNPA ratio to ~2%, while sustaining healthy specific PCR at 79%/contingent buffer @1% of loans amid rising stress in unsecured loans across industry. Management has indicated being cautious on unsecured loans (mainly PL), but believes that overall stress levels remain well below tolerable levels. ICICIB remains our preferred pick in the banking space, given its superior returns profile (RoA: >2%), top-management credibility, and strong capital/provision buffers.
Outlook
We retain BUY on ICICIB with TP of Rs1,450, rolling forward on 2.6x Sep-26E ABV (deserving premium over HDFCB @2.3x) and subsidiaries at Rs215/sh.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.